ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,263.20
      -1.69%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.30
      -0.39%
      Bitcoin
      93,541.60
      -1.00%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Mycelx Technologies Corporation (MYX) Quote

      Mycelx Technologies Corporation

      Mycelx Technologies Corporation (MYX)

      Mayne Pharma Group Ltd
      36.50
      0.00
      (0.00%)
      Closed January 13 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      36.50
      Bid
      35.00
      Ask
      40.00
      Volume
      0.00
      0.00 Day's Range 0.00
      36.00 52 Week Range 65.50
      Market Cap
      8.389M
      Previous Close
      36.50
      Open
      -
      Last Trade
      (O)
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      8,636
      Shares Outstanding
      22,983,023
      Dividend Yield
      -
      PE Ratio
      -3.10
      Earnings Per Share (EPS)
      -0.16
      Revenue
      10.91M
      Net Profit
      -3.71M

      About Mycelx Technologies Corporation

      Sector
      Water Supply
      Industry
      Water Supply
      Website
      www.mycelx.com
      Headquarters
      Norcross, Georgia, USA
      Founded
      -
      Mycelx Technologies Corporation is listed in the Water Supply sector of the London Stock Exchange with ticker MYX. The last closing price for Mycelx Technologies was 36.50p. Over the last year, Mycelx Technologies shares have traded in a share price range of 36.00p to 65.50p.

      Mycelx Technologies currently has 22,983,023 shares outstanding. The market capitalization of Mycelx Technologies is £8.39 million. Mycelx Technologies has a price to earnings ratio (PE ratio) of -3.10.

      Ask ADVFN Intelligence (AI)

      MYX Latest News

      More News

      Mycelx Tech revenue to beat revenue market expectations for 2024

      Mycelx Technologies Corp on Monday said it expects to report a pretax profit in line with market expectations for 202 ...

      January 06 2025
      Alliance News

      MyCelx Technologies Corporation Year-end Update

      MyCelx Technologies Corporation 06 January 2025   06 January 2025   MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)   Year-end Update   MYCELX Technologies Corporation ("MYCELX" or the "Company...

      January 06 2025
      RNS Regulatory News

      IN BRIEF: Mycelx wins second water treatment contract in Middle East

      es Corp - Georgia, US-based clean water and air technology - Wins its second project with an unnamed Middle East produ ...

      October 29 2024
      Alliance News

      MyCelx Technologies Corporation Project Award

      MyCelx Technologies Corporation 29 October 2024   The information contained within this Announcement is deemed by MYCELX Technologies Corporation to constitute inside information as stipulated...

      October 29 2024
      RNS Regulatory News

      MyCelx Technologies Corporation Investor Presentation via Investor Meet Company

      MyCelx Technologies Corporation 26 September 2024     26 September 2024 MYCELX Technologies Corporation ("MYCELX" or the "Company") Investor Presentation via Investor Meet Company   MYCELX...

      September 26 2024
      RNS Non-Regulatory

      MyCelx Technologies Corporation Half Year Results Statement

      MyCelx Technologies Corporation 24 September 2024   24 September 2024   MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)   Half Year Results Statement                                                 ...

      September 24 2024
      RNS Regulatory News

      MyCelx Technologies Corporation Trading Update

      MyCelx Technologies Corporation 23 September 2024   The information contained within this Announcement is deemed by MYCELX Technologies Corporation to constitute inside information as...

      September 23 2024
      RNS Regulatory News

      MyCelx Technologies Corporation Holding(s) in Company

      MyCelx Technologies Corporation 06 September 2024   Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of...

      September 06 2024
      RNS Regulatory News

      MyCelx Technologies Corporation Holding(s) in Company

      MyCelx Technologies Corporation 05 September 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN US62847T2024 Issuer Name MYCELX TECHNOLOGIES CORPORATION UK...

      September 05 2024
      RNS Regulatory News

      MyCelx Technologies Corporation Broker Option

      MyCelx Technologies Corporation 30 August 2024   THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, DISTRIBUTION OR FORWARDING, DIRECTLY...

      August 30 2024
      RNS Regulatory News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.5-3.947368421053838362258736.77392505DE
      4-0.5-1.35135135135373836700536.75976338DE
      12-3.5-8.75404136863637.72240766DE
      26-18-33.027522935854.559.5361313243.52168011DE
      52-21.5-37.06896551725865.5361819750.62687675DE
      156-36-49.655172413872.579.519.51807248.2395055DE
      260-19.5-34.82142857145686.519.52497343.37234089DE

      MYX - Frequently Asked Questions (FAQ)

      What is the current Mycelx Technologies share price?
      The current share price of Mycelx Technologies is 36.50p
      How many Mycelx Technologies shares are in issue?
      Mycelx Technologies has 22,983,023 shares in issue
      What is the market cap of Mycelx Technologies?
      The market capitalisation of Mycelx Technologies is GBP 8.39M
      What is the 1 year trading range for Mycelx Technologies share price?
      Mycelx Technologies has traded in the range of 36.00p to 65.50p during the past year
      What is the PE ratio of Mycelx Technologies?
      The price to earnings ratio of Mycelx Technologies is -3.1
      What is the cash to sales ratio of Mycelx Technologies?
      The cash to sales ratio of Mycelx Technologies is 1.05
      What is the reporting currency for Mycelx Technologies?
      Mycelx Technologies reports financial results in USD
      What is the latest annual turnover for Mycelx Technologies?
      The latest annual turnover of Mycelx Technologies is USD 10.91M
      What is the latest annual profit for Mycelx Technologies?
      The latest annual profit of Mycelx Technologies is USD -3.71M
      What is the registered address of Mycelx Technologies?
      The registered address for Mycelx Technologies is 1650 INTERNATIONAL COURT, SUITE 100, NORCROSS, GEORGIA, 30093
      What is the Mycelx Technologies website address?
      The website address for Mycelx Technologies is www.mycelx.com
      Which industry sector does Mycelx Technologies operate in?
      Mycelx Technologies operates in the WATER SUPPLY sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 66.00
      (0.00%)
      		1.65k
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 66.00
      (0.00%)
      		1.65k
      0R0XTesla Inc
      $ 388.20
      (0.00%)
      		4.24k
      0JOQJd.com Inc
      $ 72.00
      (0.00%)
      		3.03k
      0HCIAlibaba Group Holding Ltd
      $ 81.10
      (0.00%)
      		2.3k
      0R1OAmazon.com Inc
      $ 217.50
      (0.00%)
      		1.67k
      0P4FFord Motor Co
      $ 9.665
      (0.00%)
      		1.67k

      Discussion

      View Full Feed
      sunspotter sunspotter 2 minutes ago
      Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
      VPLM
      Flobewan Flobewan 13 minutes ago
      Marc loved your ides
      tinojax tinojax 14 minutes ago
      I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
      PLUG
      mrfence mrfence 16 minutes ago
      Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
      [yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
      FMCC FNMA
      IVRT IVRT 33 minutes ago
      In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
      BMXI
      DewDiligence DewDiligence 33 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      ENTA
      DewDiligence DewDiligence 34 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      Guido2 Guido2 35 minutes ago
      This is DUE DILIGENCE! Thank you Free Fannie.

      https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
      FNMA
      StockItOut StockItOut 41 minutes ago
      That Xeriant PR excellently written with bullshit:

      ""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

      "the Company used the data to make several key
      XERI
      gitreal gitreal 44 minutes ago
      You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
      BMXI
      RichieBoy RichieBoy 50 minutes ago
      Jim wrote a blurb about seeking more US business.

      Help you out any? 🤨
      AFFU
      DesktopDR DesktopDR 51 minutes ago
      Any news or updates?
      VPLM
      Tahoe2468 Tahoe2468 54 minutes ago
      .0915 by Thursday....... 
      KRTL
      skitahoe skitahoe 55 minutes ago
      Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

      According to Google, GBM ha
      NWBO
      fuagf fuagf 1 hour ago
      You are right about the crafty, evil, smart. Authoritarian methods have been in full view
      in capturing America. While we work to do the right things they plot to capture the lot.
      facts_matter14 facts_matter14 1 hour ago
      If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






      .
      SRMX
      StockItOut StockItOut 1 hour ago
      Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
      XERI
      fuagf fuagf 1 hour ago
      He would smother any question with words.
      Shawonsarker84 Shawonsarker84 1 hour ago
      $HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



      https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
      HMBL XTIA
      chen1992 chen1992 1 hour ago
      https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

      https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
      TGLO
      FNM500K FNM500K 1 hour ago
      Oh noooooo.....
      FNMA
      StockItOut StockItOut 1 hour ago
      OTC filings and attorney statements. my error.

      Point that it is on you to prove your claim, that:
      "There's no contract employees. There's no production shafts."

      Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

      I
      BMXI
      Money4Nothing-M4N Money4Nothing-M4N 2 hours ago
      Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

      And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
      KBLB
      rx7171 rx7171 2 hours ago
      Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

      To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
      AVXL

      Your Recent History

      LSE
      MYX
      Mycelx Technologies
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads